Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2022, 10(3), 56-58
DOI: 10.12691/AJMCR-10-3-4
Case Report

Corona Lungs and Strawberry Tongues

Sabina Kumar1, , Umeh Chukwuemeka1, John Carvalho1, Laura Tuscher2, Sobiga Ranchithan3, Rakesh Gupta1, Chawki Harfouch1, Pranav Barve1 and Sumanta Chaudhuri1

1Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA

2Divison of Medicine, St. George’s University, School of Medicine, West Indies, Grenada

3Division of Medicine, American University of Antigua, Osbourn, Antigua & Barbuda

Pub. Date: March 11, 2022
Full Text PDF

Cite this paper

Sabina Kumar, Umeh Chukwuemeka, John Carvalho, Laura Tuscher, Sobiga Ranchithan, Rakesh Gupta, Chawki Harfouch, Pranav Barve and Sumanta Chaudhuri. Corona Lungs and Strawberry Tongues. American Journal of Medical Case Reports. 2022; 10(3):56-58. doi: 10.12691/AJMCR-10-3-4

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is one of several severe complications of COVID-19 seen in children. The United States Center for Disease Control diagnostic guidelines for MIS-C include age <21 years, 24-hour history of fever ≥38.0ºC, severe illness necessitating hospitalization, two or more organ system involvement, laboratory evidence of inflammation, laboratory or epidemiologic evidence of SARS-CoV-2, and a lack of alternative diagnosis. This case report focuses on one patient who met six out of the seven cardinal features of MIS-C but fell outside the average age range. Unfortunately, the patient died from complications of COVID-19. Since our patient had multiple risk factors, including obesity and Hispanic ethnicity the pathogenesis of the disease occurring in our patient was likely identical to that which occurs in MIS-C. Due to a significant chance of mortality in patients with MIS-C and COVID-19, it is important to consider this diagnosis in older adolescents and young adults. This patient’s unfortunate outcome urges prompt greater suspicion for this rare and life-threatening complication, even though this patient is older than the typical MIS-C patient.

Keywords

COVID-19, MIS-C, SARS-CoV-2, Multisystem Inflammatory Syndrome in Children

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Dawood, Fatimah S., et al. “Incidence rates, household infection risk, and clinical characteristics of SARS-CoV-2 infection among children and adults in Utah and New York City, New York.” JAMA pediatrics (2021).
 
[2]  Viner, Russell M., et al. “Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents.” Archives of disease in childhood 106.8 (2021): 802-807.
 
[3]  Payne AB, Gilani Z, Godfred-Cato S, et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw Open. 2021; 4(6): e2116420.
 
[4]  Son, Mary Beth F., and Kevin Friedman. “Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children.” Up to Date (2020).
 
[5]  Payne, Amanda B., et al. “Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.” JAMA network open 4.6 (2021): e2116420-e2116420.
 
[6]  Feldstein, Leora R., et al. “Multisystem inflammatory syndrome in US children and adolescents.” New England Journal of Medicine 383.4 (2020): 334-346.
 
[7]  Steinberg, Eric, Ellsworth Wright, and Beth Kushner. “In young adults with COVID-19, obesity is associated with adverse outcomes.” Western Journal of Emergency Medicine 21. 4 (2020): 752.
 
[8]  Graff, Kelly, et al. “Risk factors for severe COVID-19 in children.” The Pediatric Infectious Disease Journal 40.4 (2021): e137-e145.
 
[9]  Radia, Trisha, et al. “Multisystem inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.” Paediatric respiratory reviews 38 (2021): 51-57.
 
[10]  Nakra, Natasha A., et al. “Multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management.” Children 7.7 (2020): 69.
 
[11]  Son, Mary Beth F., and Kevin Friedman. “COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis.” Up to Date (2021).
 
[12]  Cattalini, Marco, et al. “Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics.” Italian journal of pediatrics 47.1 (2021): 1-6.
 
[13]  Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017; 13(4): 851-863.